PerkinElmer Launches Operetta High Content Screening (HCS) System

Industry leader in life sciences imaging and cellular technologies brings
benefits of HCS for drug discovery and biological research to almost any
laboratory through benchtop device
SAN FRANCISCO--(Business Wire)--
At the 6th Annual High Content Analysis Conference in San Francisco,
PerkinElmer, Inc., a global leader focused on the health and safety of people
and their environment, today announced the launch of its Operetta system, a
benchtop instrument that provides leading edge High Content Screening (HCS) and
High Content Analysis (HCA) capabilities to drug discovery and cellular science
research laboratories.

Operetta is an HCS/HCA instrument platform that employs PerkinElmer`s
proprietary new Harmony software which provides researchers with easy to use
building blocks for creating user configurable workflows via simple step-by-step
procedures. An extensive range of ready-made solutions for frequently used image
analysis tasks is pre-installed. Also installed is a scalable database for image
management, and data analysis or retrieval. The Harmony software provides tools
to develop high content assays, image analysis storage and retrieval, as well as
remote access capability.

"The Operetta platform and Harmony software extend PerkinElmer`s portfolio in
cellular imaging and bring the benefits of HCS and HCA to almost any life
sciences laboratory," said Richard M. Eglen, Ph.D., president, Bio-discovery,
PerkinElmer. "Our expertise in cellular imaging provides us with unique insights
into common issues encountered in implementing HCS research. We are now
providing this critical knowledge to Operetta users, so they can easily and
rapidly optimize imaging studies for their cell science research."

The Operetta instrument is designed to allow maximum functionality in the
smallest possible footprint. A large field of view and multi-processor
technology facilitates high speed data acquisition and analysis. A wide range of
objectives and filters, bar-coded for error-free operation, enables a wide range
of assays and plates. This compact design fits almost any size laboratory,
allowing a flexible and versatile solution to suit the needs of a cellular
imaging research facility.

The key features of the Operetta system include:

* Exceptional image quality with alignment-free illumination
* Rapid image processing using multi-processor technology
* Intuitive user interface
* Extensive series of preconfigured image analysis applications
* Powerful image segmentation includes automatic parameter optimization for ease
of use
* Easy to configure building blocks for custom image analysis.

Operetta Application Guide

To help new HCS users, PerkinElmer provides a step-by-step handbook to analyzing
results, guiding researchers through the process, from using a ready-made
solution to designing a new image analysis sequence from the building blocks
provided.

About PerkinElmer, Inc.

PerkinElmer, Inc. is a global leader focused on ensuring the health and safety
of people and their environment. The Company reported revenue of $1.8 billion in
2007, has approximately 9,100 employees serving customers in more than 150
countries, and is a component of the S&P 500 Index. Additional information is
available through www.perkinelmer.com or 1-877-PKI-NYSE.

PerkinElmer, Inc.
Mario Fante, 781-663-5602
mario.fante@perkinelmer.com

Copyright Business Wire 2009